Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Express Scripts
Merck
Dow
McKesson

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

Litigation Details for Mallinckrodt IP v. B. Braun Medical Inc. (D. Del. 2017)

See Plans and Pricing

« Back to Dashboard

Mallinckrodt IP v. B. Braun Medical Inc. (D. Del. 2017)

Docket   Start Trial Date Filed 2017-05-31
Court District Court, D. Delaware Date Terminated
Cause 35:0145 Assigned To Leonard Philip Stark
Jury Demand None Referred To
Parties B. BRAUN MEDICAL INC.; MALLINCKRODT HOSPITAL PRODUCTS INC.; MALLINCKRODT IP; MALLINCKRODT IP UNLIMITED COMPANY
Patents 9,399,012; 9,610,265
Attorneys Benjamin J. Schladweiler; Gregory Erich Stuhlman; Jeremy A. Tigan; Stephen J. Kraftschik; Steven T. Margolin; Thomas C. Grimm
Firms Greenberg Traurig, the Nemours Building; Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in Mallinckrodt IP v. B. Braun Medical Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Mallinckrodt IP v. B. Braun Medical Inc. (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
2017-08-03 16 U.S. Patent No. 9,399,012 (“the ’012 patent”) and U.S. Patent No. 9,610,265 (“the ’265 patent”) (collectively… action for infringement of the patents-in-suit pursuant to the Patent Laws of the United States, 35 … THE PATENTS-IN-SUIT 21. The ’012 patent, titled “Reduced Dose Intravenous…sole assignee of the ’012 patent. A true and correct copy of the ’012 patent is attached as Exhibit A.…sole assignee of the ’265 patent. A true and correct copy of the ’265 patent is attached as Exhibit B. External link to document
2017-06-01 6 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,399,012 B2; 9,610,265 B2; .… 31 May 2017 1:17-cv-00660 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
AstraZeneca
Mallinckrodt
Johnson and Johnson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.